These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21277463)

  • 1. [Immediate changes in intraocular pressure after an intravitreal injection of 2.5 mg of bevacizumab].
    Wu L; Evans T
    Arch Soc Esp Oftalmol; 2010 Nov; 85(11):364-9. PubMed ID: 21277463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of blood pressure and intraocular pressure changes in hypertensive and nonhypertensive patients after intravitreal bevacizumab injection.
    Lee K; Yang H; Lim H; Lew HM
    Retina; 2009; 29(10):1409-17. PubMed ID: 19816242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
    Frenkel MP; Haji SA; Frenkel RE
    Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of intraocular pressure after intravitreal injection of bevacizumab (avastin).
    Falkenstein IA; Cheng L; Freeman WR
    Retina; 2007 Oct; 27(8):1044-7. PubMed ID: 18040242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term intraocular pressure changes after intravitreal injection of bevacizumab.
    Hollands H; Wong J; Bruen R; Campbell RJ; Sharma S; Gale J
    Can J Ophthalmol; 2007 Dec; 42(6):807-11. PubMed ID: 18026202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents.
    Kim JE; Mantravadi AV; Hur EY; Covert DJ
    Am J Ophthalmol; 2008 Dec; 146(6):930-4.e1. PubMed ID: 18775528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
    Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
    J Glaucoma; 2012; 21(4):241-7. PubMed ID: 21423038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.
    Fuest M; Kotliar K; Walter P; Plange N
    Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent elevation of intraocular pressure following intravitreal injection of bevacizumab.
    Segal O; Ferencz JR; Cohen P; Nemet AY; Nesher R
    Isr Med Assoc J; 2013 Jul; 15(7):352-5. PubMed ID: 23943979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide.
    Benz MS; Albini TA; Holz ER; Lakhanpal RR; Westfall AC; Iyer MN; Carvounis PE
    Ophthalmology; 2006 Jul; 113(7):1174-8. PubMed ID: 16647122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.
    Hoang QV; Mendonca LS; Della Torre KE; Jung JJ; Tsuang AJ; Freund KB
    Ophthalmology; 2012 Feb; 119(2):321-6. PubMed ID: 22054994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide and intraocular pressure.
    Smithen LM; Ober MD; Maranan L; Spaide RF
    Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
    Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
    Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
    Lemos V; Cabugueira A; Noronha M; Abegão Pinto L; Reina M; Branco J; Gomes T
    Ophthalmologica; 2015; 233(3-4):162-8. PubMed ID: 25791262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure elevation after injection of triamcinolone acetonide: a multicenter retrospective case-control study.
    Inatani M; Iwao K; Kawaji T; Hirano Y; Ogura Y; Hirooka K; Shiraga F; Nakanishi Y; Yamamoto H; Negi A; Shimonagano Y; Sakamoto T; Shima C; Matsumura M; Tanihara H
    Am J Ophthalmol; 2008 Apr; 145(4):676-681. PubMed ID: 18243153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension.
    Kim GN; Han YS; Chung IY; Seo SW; Park JM; Yoo JM
    Semin Ophthalmol; 2013 Mar; 28(2):61-7. PubMed ID: 23448557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.